David Withers

David Withers

University of Birmingham

H-index: 45

Europe-United Kingdom

About David Withers

David Withers, With an exceptional h-index of 45 and a recent h-index of 32 (since 2020), a distinguished researcher at University of Birmingham, specializes in the field of Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Protocol for transcutaneous tumor photolabeling to track immune cells in vivo using Kaede mice

Abstract LB263: A first-in-class multimodal immunotherapy for induction of tertiary lymphoid structures as a novel therapeutic strategy for solid tumors

Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity

Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity

Bcl6 is a subset-defining transcription factor of lymphoid tissue inducer-like ILC3

LYVE-1+ macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer

Inhibitory IL-10-producing CD4+ T cells are T-bet-dependent and facilitate cytomegalovirus persistence via coexpression of arginase-1

Time-, tissue-and treatment-associated heterogeneity in tumour-residing migratory DCs

David Withers Information

University

Position

Principal Investigator

Citations(all)

7091

Citations(since 2020)

3931

Cited By

4684

hIndex(all)

45

hIndex(since 2020)

32

i10Index(all)

79

i10Index(since 2020)

60

Email

University Profile Page

Google Scholar

David Withers Skills & Research Interests

Immunology

Top articles of David Withers

Protocol for transcutaneous tumor photolabeling to track immune cells in vivo using Kaede mice

STAR protocols

2024/6/21

Abstract LB263: A first-in-class multimodal immunotherapy for induction of tertiary lymphoid structures as a novel therapeutic strategy for solid tumors

Cancer Research

2024/4/5

Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity

Nature Communications

2024/1/24

Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity

Nature Communications

2024/1/24

Bcl6 is a subset-defining transcription factor of lymphoid tissue inducer-like ILC3

Cell reports

2023/11/28

LYVE-1+ macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer

Developmental Cell

2023/9/11

Inhibitory IL-10-producing CD4+ T cells are T-bet-dependent and facilitate cytomegalovirus persistence via coexpression of arginase-1

Elife

2023/7/13

Time-, tissue-and treatment-associated heterogeneity in tumour-residing migratory DCs

bioRxiv

2023/7/3

ILC3s select microbiota-specific T regcells to establish tolerance in the gut

The Journal of Immunology

2023/5/1

Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV-and LXR-dependent manner

Cell reports

2023/3/28

Rapid establishment of a tumor-retained state curtails the contribution of conventional NK cells to anti-tumor immunity in solid cancers

bioRxiv

2023

Migration of stem-like CD8 T cells between tissue microenvironments underpins successful anti-tumour immune responses

2023/1/1

Group 3 innate lymphocytes make a distinct contribution to type 17 immunity in bladder defence

Iscience

2022/7/15

Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria

Cell host & microbe

2022/7/13

ILC3s select for RORγt+ Tregs and establish tolerance to intestinal microbiota

bioRxiv

2022/4/26

In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue

Journal of Experimental Medicine

2022/4/26

ILC killer: Qu’est-ce que c’est?

2022/4/8

Perivascular macrophages collaborate to facilitate chemotherapy resistance in cancer

bioRxiv

2022/2/4

Heterogeneity and function of conventional dendritic cells from early to adult life

2022

Dynamic analyses of tumor microenvironment modulation by CAN-2409 treatment using Kaede photoconvertible transgenic mice

J Exp Med

2022

See List of Professors in David Withers University(University of Birmingham)

Co-Authors

academic-engine